Trium Capital discloses 10.82% stake in Mural Oncology
PositiveFinancial Markets

Trium Capital has announced a significant investment by acquiring a 10.82% stake in Mural Oncology, a move that highlights confidence in the company's potential in the oncology sector. This investment is important as it not only strengthens Mural's financial position but also signals to the market that Trium believes in the innovative approaches Mural is taking in cancer treatment.
— Curated by the World Pulse Now AI Editorial System